de Lavallaz, Jeanne du Fay
Mézier, Julien
Mertz, Lara
Mannhart, Diego
Serban, Teodor
Knecht, Sven
Abid, Qurrat-ul-ain
Nguyen, Tai Tri
Kühne, Michael
Sticherling, Christian
Huang, Henry
Gold, Michael R.
Badertscher, Patrick http://orcid.org/0000-0001-9751-0557
Funding for this research was provided by:
University of Basel
Article History
Received: 6 October 2022
Accepted: 8 November 2022
First Online: 21 November 2022
Declarations
:
: The study received approval of the ethics’ committee.
: Not applicable.
: Sven Knecht has received funding of the “Stiftung für Herzschrittmacher und Elektrophysiologie.”Michael Kühne reports personal fees from Bayer, personal fees from Böhringer Ingelheim, personal fees from Pfizer BMS, personal fees from Daiichi Sankyo, personal fees from Medtronic, personal fees from Biotronik, personal fees from Boston Scientific, personal fees from Johnson & Johnson, personal fees from Roche, grants from Bayer, grants from Pfizer, grants from Boston Scientific, grants from BMS, grants from Biotronik, and grants from Daiichi Sankyo, all outside the submitted work.Christian Sticherling is a Member of Medtronic Advisory Board Europe and Boston Scientific Advisory Board Europe, received educational grants from Biosense Webster and Biotronik and a research grant from the European Union’s FP7 program and Biosense Webster, and lecture and consulting fees from Abbott, Medtronic, Biosense-Webster, Boston Scientific, Microport, and Biotronik, all outside the submitted work.Patrick Badertscher has received research funding from the “University of Basel,” the “Stiftung für Herzschrittmacher und Elektrophysiologie,” the “Freiwillige Akademische Gesellschaft Basel,” and Johnson & Johnson, all outside the submitted work and reports personal fees from Abbott.Jeanne du Fay de Lavallaz has received research funding from the “University of Basel” and from the “Swiss Heart Foundation.”Henry Huang has received research funding from Medtronic, educational grants from Medtronic, Biotronik, Abbott, and Boston Scientific, and consulting fees from Biosense-Webster and Cardiofocus.Michael Gold is a consultant to Boston Scientific and Medtronic, as well as on steering committees with Boston Scientific, Abbott, and Medtronic.Others have nothing to declare.